INTRODUCTION
============

Nasal colonization by *Staphylococcus spp.* begins soon after birth, increases during infancy and decreases in adulthood ([@b9]). Colonized individuals can develop endogenous infections with strains that disseminate from the nasopharynx, which constitute 80% of cases of invasive *Staphylococcus aureus* infection. Approximately 20% of adults are carriers of *S.aureus* in the nasopharynx, 30% are intermittent carriers, and 50% are non-carriers ([@b15], [@b45]).

*Staphylococcus aureus* and coagulase-negative *Staphylococcus spp.* are among the most prevalent pathogens of dialysis and kidney transplant patients ([@b1], [@b17]). These individuals possess risk factors for colonization and infection with multidrug-resistant *S. aureus* because of their frequent and prolonged use of antimicrobials. Moreover, these patients undergo frequent admission to the hospital and invasive procedures and maintain contact with colonized patients and professionals. Kidney transplant recipients are at additional risk due to the use of immunosuppressive therapies, which are initiated soon after transplant ([@b19], [@b36]).

*S. aureus* is highly versatile in acquiring antimicrobial resistance, especially to beta-lactam drugs such as oxacillin ([@b4], [@b26]). Beta-lactam resistance is encoded by the *mec*A gene, which is located on the staphylococcal cassette chromosome *mec* (SCC*mec*). SCC*mec* confers resistance to oxacillin and is transferable between species of *Staphylococcus* ([@b12]). In addition to the *mecA* gene, other resistance mechanisms can be involved, such as enzymatic degradation of antimicrobials, alterations in membrane permeability and active site alteration ([@b5]).

Polymerase chain reaction (PCR) using specific primers ([@b40]) is one of several molecular techniques utilized for bacterial studies. It is possible to detect antimicrobial resistance genes, differentiate samples with identical phenotypes, establish dissemination routes, relate isolates from different sources and compare the genotypes of samples dispersed in the environment using PCR ([@b23]).

PCR amplification of repetitive sequences (REP-PCR) can be used to better understand the evolutionary relationships between *S. aureus* clones that are resistant to oxacillin (ORSA) ([@b10]) and to trace and identify the transmission source. The RW3A primer is a repetitive sequence that permits the genetic distinction of phenotypically equivalent strains of *S. aureus* ([@b35]).

Considering the importance of nasal carriage of *S. aureus* in the epidemiology of staphylococcal infection and that a significant percentage of these infections are of endogenous origin ([@b29]), the following objectives were proposed for this study: to investigate the frequency of nasal carriage of *S. aureus* among dialysis and kidney transplant patients, to identify the resistance profiles of these isolates for commonly used antimicrobial therapies; to verify the presence of the m*ecA* gene in oxacillin-resistant samples and to identify the genetic profile of the samples and correlate the findings.

MATERIALS AND METHODS
=====================

Study site and population
-------------------------

This correlational, exploratory and descriptive study included patients who were treated at the Santa Casa de Maringá hospital dialysis center, including those undergoing dialysis and those who received a kidney transplant. The study population was composed of 159 individuals, including 111 dialysis patients and 48 kidney transplant recipients. Of the dialysis patients, 54,1% (60/111) were male and 45.9% (51/111) were female, and age varied between 15 and 93 years old. Among the kidney transplant patients, 64.5% (31/48) were male and 35.4% (17/48) were female, and age varied between 18 and 64 years old. One sample per patient was collected during the period from June to November 2009.

Laboratory procedures
---------------------

**Collection, identification and storage of biological material:** Samples from the nares were obtained with sterile swabs that were subsequently placed into tubes containing Trypticase Soy Broth (TSB) with 6.5% NaCl, incubated for 24 hours in an incubator and plated on Petri dishes containing mannitol salt agar (MSA) (Becton, Dickinson and Company, BD Diagnostic Systems, USA) ([@b13]). After incubation at 37°C for 24--48 hours, Gram staining ([@b41]) was performed on suspected *S. aureus* colonies, and those identified as clustered Gram-positive cocci were subjected to the coagulase test ([@b22]). After identification, samples were stored in TSB medium containing 20% glycerol at -20º C.

Antimicrobial sensitivity
-------------------------

**Disk diffusion assay:** Disk diffusion assays were performed according to the standards recommended in document M2-A10 from the *Clinical and Laboratory Standards Institute* (CLSI) ([@b5]) with the following antimicrobials: 1 μg oxacillin, 30 μg cefoxitin, 10 μg gentamicin, 30 μg tetracycline, 10 μg penicillin G, 15 μg azithromycin, 2 μg clindamycin, 75 μg trimethoprim/sulfamethoxazole, 30 μg doxycycline, 5 μg rifampin, 30 μg teicoplanin or 5 μg ofloxacin. *S. aureus* control samples were obtained from the American Type Culture Collection (ATCC). One sample was sensitive (ATCC 25923) and one was resistant to oxacillin (ATCC 43300). Halo diameters were compared with those described in [Table 1](#tbl1){ref-type="table"}, document M100-S20 of the *Clinical and Laboratory Standards Institute* ([@b6]). Results that were interpreted as intermediate were considered to be resistant.

###### 

Distribution of antimicrobial resistance by disk diffusion to *S. aureus* isolated from dialysis and kidney transplant patients at Santa Casa hospital of Maringá, 2009.

  Antimicrobianos              Transplantados Renais   Diálise        Total
  ---------------------------- ----------------------- -------------- -------------
  Penicilina                   (34/36) 94%             (50/55) 90%    (84/91) 92%
  Cefoxitina                   (06/36) 16%             (04/55) 3,6%   (10/91) 11%
  Oxacilina                    (06/36) 16%             (02/55) 7,2%   (8/91) 8,7%
  Azitromicina                 (24/36) 66%             (30/55) 54%    (54/91) 59%
  Clindamicina                 (24/36) 66%             (21/55) 38%    (45/91) 49%
  Trimetropin/sulfametoxazol   (19/36) 52%             (16/55) 29%    (35/91) 38%
  Tetraciclina                 (26/36) 72%             (20/55) 36%    (46/91) 50%
  Doxicilina                   (09/36) 25%             (13/55) 23%    (22/91) 24%
  Rifampicina                  (07/36) 19%             (06/55) 10%    (13/91) 14%
  Gentamicina                  (09/36) 25%             (09/55) 16%    (18/91) 19%
  Teicoplamina                 (00/36) 0%              (00/55) 0%     (0/91) 0%
  Ciprofloxacina               (24/36) 66%             (16/55) 29%    (40/91) 43%

**Determination of Minimum Inhibitory Concentration (MIC):** MIC was determined for oxacillin and vancomycin by the agar dilution method following the methodology proposed in document M7-A8 from the *Clinical and Laboratory Standards Institute* ([@b7]). ATCC samples 29213 and 43300 were used as positive controls. Readings of results were performed according to standards described in [Table 1](#tbl1){ref-type="table"} of document M100-S20 from the *Clinical and Laboratory Standards Institute* ([@b6]).

Polymerase Chain Reaction
-------------------------

**DNA Extraction:** For PCR with various primers, DNA was extracted from *S. aureus* samples with cetyltrimethylammonium bromide (CTAB) ([@b14]).

**Identification of the** ***mecA*** **gene and genotyping:** The *mecA* gene was identified in oxacillin-resistant samples with primers MRS1- 5' TAGAAATGACTGAACGTCCG 3' and MRS2- 5' TTGCGATCAATGTTACCGTAG 3' ([@b38], [@b43]). The amplified products were visualized with gel electrophoresis on a 1.5% agarose gel stained with ethidium bromide. A 154-base pair (bp) amplicon indicated the presence of the *mecA* gene*.*

Genetic typing of the samples was performed with PCR using the RW3A primer (5'- TCGCTCAAAACAACGACACC 3') ([@b44]). The amplified product was analyzed after separation on a 1.5% agarose gel stained with ethidium bromide. Analysis of the standards was performed visually, and the degree of similarity between the samples was obtained using NT SYS, and the results are presented in a dendrogram.

Ethical Considerations
----------------------

This study observed and respected all of the rules contained in the 196/96 Resolution of the National Council of Health and was approved by the Permanent Committee for Ethics in Research Involving Human Subjects (Comitê Permanente de Ética em Pesquisa Envolvendo Seres Humanos - COPEP) of the UEM, under registration number 212/2009 ([@b3]).

RESULTS AND DISCUSSION
======================

Among the 48 kidney transplant recipients, 36 (75%) were positive for *S. aureus* in their nares, whereas 55 (49%) of the 111 dialysis patients were carriers. These high rates of nasal colonization are comparable with other reports that show similar rates ([@b33]). Palos ([@b34]) found a *S. aureus* carriage rate of 84.7% among health care professionals. In the general population, an average rate of 37.2% was observed by Kluytmans *et al*. ([@b23]), who found higher carriage frequencies among patients who were repeatedly subjected to skin puncture, such as patients receiving hemodialysis or continuous ambulatory peritoneal dialysis. Because the carriage of this bacterium appears to be a predictor of infection, its identification has become a necessary prevention strategy ([@b18]).

Ten samples were resistant to cefoxitin, among which eight were also resistant to oxacillin on a disk diffusion

antibiogram. The CLSI ([@b6]) recommends combining oxacillin and cefoxitin resistance results so that readings are more precise and reliable. The identification of oxacillin resistance is epidemiologically important because this drug is a marker of resistance to other groups of beta-lactam antibiotics that target the bacterial cell wall. Changes in penicillin binding proteins (PBPs) diminish their affinity for the antimicrobial ([@b28]). Nosocomial and community-associated penicillinase-producing staphylococci may also be resistant to other classes of antimicrobials, such as macrolides, aminoglycosides, streptomycin and tetracycline ([@b24]).

The observed resistance rate for oxacillin (11%) and the total sensitivity to vancomycin correspond to the results obtained by Faria ([@b16]). The complete sensitivity to vancomycin among the samples observed in this study was expected because in Brazil, few studies have reported the isolation of samples resistant to this drug ([@b24], [@b30], [@b32]). Studies have warned of the need for policies to prevent the inappropriate or unnecessary use of the glycopeptides vancomycin and teicoplanin and to reduce the opportunity for the emergence and spread of resistant or insensitive strains ([@b8]).

We observed 100% sensitivity to teicoplanin and approximately 90% resistance to penicillin, 14% to rifampin and 59% to azithromycin. High rates of resistance to penicillin among *S. aureus* strains have been observed since 1959, when this frequency was 80%, which has since extended to amoxicillin and to ampicillin ([@b27]). The prevalence of resistance to rifampicin (14%) and gentamicin (19%) and the complete sensitivity to teicoplanin observed in this study are similar to results obtained by Menegoto and Picoli ([@b31]). [Table 1](#tbl1){ref-type="table"} lists the results of antimicrobial susceptibility testing by the disk diffusion assay for *S. aureus* samples isolated from dialysis and kidney transplant patients from the Santa Casa de Maringá hospital in 2009.

MIC determination was utilized to confirm the oxacillin resistance profile observed by disk diffusion and to test for vancomycin resistance. The ten samples that were resistant to cefoxitin by disk diffusion were confirmed by MIC, which varied between 4 μg/ml and 256 μg/ml. Approximately 30% (3/10) of the samples demonstrated a MIC of 4 μg/ml, 10% (1/10) exhibited a MIC of 8 μg/ml, 20% (2/10) showed a MIC of 16 μg/ml, and 40% (4/10) demonstrated a MIC of 256 μg/ml. For two samples, the results of the disk diffusion assay differed from those of the MIC test for oxacillin resistance. Both samples exhibited sensitivity by disk diffusion and resistance by MIC, with values equal to the 4-μg/ml threshold. These results support the proposal of the CLSI ([@b5]), which advocates for the confirmation of results from the disk diffusion assay with those of the MIC test using standard strains (ATCC) that are known to be sensitive and resistant.

The results of antimicrobial susceptibility testing demonstrated that of the ten samples resistant to oxacillin by MIC, six (60%) exhibited a MIC of 2 μg/ml and four (40%) demonstrated a MIC of 1 μg/ml for vancomycin, with all defined as vancomycin-sensitive. Combining the results of sensitivity testing (MIC) for oxacillin and vancomycin did not reveal an association, independent of the observed values, because all of the samples were sensitive to vancomycin.

*S. aureus* antimicrobial resistance may be chromosomally encoded or mediated by plasmids. With respect to oxacillin resistance, the hyperproduction of beta-lactamases, changes in the binding capacity of PBPs or the presence of an altered PBP known as PBP2a may be observed ([@b42]). This altered PBP is encoded by a chromosomal gene known as *mecA,* which is responsible for the intrinsic resistance of staphylococci to oxacillin and all of the beta-lactam antibiotics ([@b11]).

The presence of the *mecA* gene was identified in eight of the ten samples (80%) that were resistant to oxacillin by MIC. A previous study by Faria ([@b16]) reported similar percentages in samples from the community. More recent studies have demonstrated the efficacy of the disk diffusion assay for cefoxitin as a substitute marker for the detection of oxacillin resistance by the *mecA* gene ([@b2], [@b39]).

The degree of similarity between 48 of the 55 samples isolated from the group of dialysis patients was evaluated using PCR with the RW3A primer. No amplification product was obtained from seven of the samples. Among the 48 typed samples, 27 had a degree of similarity greater than 80%, and the remaining isolates ([@b21]) exhibited a degree of similarity that varied between 20% and 80%.

Comparisons among 16 of the 48 samples revealed eight genotypes, and distinct profiles were observed for the remaining samples. This result signifies the presence of strains with identical genotypes; however, no one single genotype was dispersed throughout the dialysis unit of this institution. The results of the genetic similarity analysis with the RW3A primer of the *S. aureus* samples isolated from dialysis patients are presented in [Figure 1](#fig1){ref-type="fig"}.
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The results of genetic similarity testing revealed that of the 36 *S. aureus* samples isolated from kidney transplant patients, two exhibited 95% similarity, eight demonstrated approximately 90% similarity, and the remaining samples ([@b28]) showed less than 80% similarity. Similar to the dialysis group, a single genotype that was disseminated throughout the institution was not identified among kidney transplant recipients, as 100% similarity was not observed. The results of genotyping with the RW3A primer for the analysis of genetic similarity among the *S. aureus* samples isolated from transplant patients are presented in [Figure 2](#fig2){ref-type="fig"}.
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With genetic typing, a more homogenous profile was observed among the samples isolated from dialysis patients than among those isolated from kidney transplant patients. Few studies have reported using the RW3A primer for typing *S. aureus* samples isolated from humans. A study performed by Santos and Darini ([@b37]) identified little similarity among *S. aureus* isolates from children and employees of a hospital; however, the authors emphasized the important role of genotyping in the research design because the antibiogram alone did not provide sufficient criteria for sample distinction ([@b37]).

Among the sixteen *S. aureus* samples isolated from dialysis patients, eight genotypes that grouped in pairs were identified. In seven of these eight genotypes, fourteen samples were sensitive to oxacillin, and in one genotype, two isolates exhibited different profiles, with one oxacillin-sensitive and one oxacillin-resistant sample. Among the samples isolated from transplant patients, only two exhibited 95% similarity, and both were sensitive to oxacillin. Establishing a correlation between antimicrobial resistance and dissemination of clonal *S. aureus* groups is an important tool during outbreaks or in endemic settings. Jones et al. ([@b20]) demonstrated using PCR with the RW3A primer the existence of clones among mupirocin-resistant samples of MRSA from the nares of patients admitted to the Surgical Intensive Care Unit. In our study, no correlation was observed between genetic similarity and oxacillin sensitivity and resistance.

Considering the high rate of *S. aureus* carriage and the multidrug resistance profile of the samples demonstrated in this study, we recommend the implementation of prevention and control measures, including decontamination of nasal carriers, restricted use of the antimicrobials commonly used in clinical practice to which resistance is most frequent, active search for carriers among contacts, tracking of dissemination sources and a detailed study of antimicrobial resistance with reliable methodologies. Moreover, the susceptibility to mupirocin needs to be determined with greater methodological rigor, and its use in the nasal decontamination of carriers of multidrug-resistant strains should be evaluated.
